Terms: = Ovarian cancer AND ERBB4, MGC138404, 2066, ENSG00000178568, Q15303, p180erbB4, HER4
73 results:
1. [Fertility preservation in female cancer patients.].
Vesztergom D; Székely B; Hegyi B; Masszi A; Pintér T; Csákó B; Kenessey I; Rubovszky G; Novák Z
Orv Hetil; 2023 Jul; 164(29):1134-1145. PubMed ID: 37481767
[TBL] [Abstract] [Full Text] [Related]
2. Identification of genes and pathways associated with sex in Non-smoking lung cancer population.
Xu L; Wang L; Cheng M
Gene; 2022 Jul; 831():146566. PubMed ID: 35577039
[TBL] [Abstract] [Full Text] [Related]
3. Systematic analysis and molecular profiling of EGFR allosteric inhibitor cross-reactivity across the proto-oncogenic ErbB family kinases by integrating dynamics simulation, energetics calculation and biochemical assay.
Ma Y; Qi B; Ning M; Zhang L; An Z; Zhao J
Eur Biophys J; 2022 Apr; 51(3):283-295. PubMed ID: 35307752
[TBL] [Abstract] [Full Text] [Related]
4. RNA-binding protein IGF2BP2 enhances circ_0000745 abundancy and promotes aggressiveness and stemness of ovarian cancer cells via the microRNA-3187-3p/erbb4/PI3K/AKT axis.
Wang S; Li Z; Zhu G; Hong L; Hu C; Wang K; Cui K; Hao C
J Ovarian Res; 2021 Nov; 14(1):154. PubMed ID: 34774079
[TBL] [Abstract] [Full Text] [Related]
5. The Anti-HER3 mAb Seribantumab Effectively Inhibits Growth of Patient-Derived and Isogenic Cell Line and Xenograft Models with Oncogenic
Odintsov I; Lui AJW; Sisso WJ; Gladstone E; Liu Z; Delasos L; Kurth RI; Sisso EM; Vojnic M; Khodos I; Mattar MS; de Stanchina E; Leland SM; Ladanyi M; Somwar R
Clin Cancer Res; 2021 Jun; 27(11):3154-3166. PubMed ID: 33824166
[TBL] [Abstract] [Full Text] [Related]
6. Combined Poziotinib with Manidipine Treatment Suppresses ovarian cancer Stem-Cell Proliferation and Stemness.
Lee H; Kim JW; Lee DS; Min SH
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33036254
[TBL] [Abstract] [Full Text] [Related]
7. MicroRNA-936/erbb4/Akt axis exhibits anticancer properties of gastric cancer through inhibition of cell proliferation, migration, and invasion.
Liu S; Gong Y; Xu XD; Shen H; Gao S; Bao HD; Guo SB; Yu XF; Gong J
Kaohsiung J Med Sci; 2021 Feb; 37(2):111-120. PubMed ID: 33021020
[TBL] [Abstract] [Full Text] [Related]
8. Emerging roles for the GPI-anchored tumor suppressor OPCML in cancers.
Antony J; Zanini E; Birtley JR; Gabra H; Recchi C
Cancer Gene Ther; 2021 Feb; 28(1-2):18-26. PubMed ID: 32595215
[TBL] [Abstract] [Full Text] [Related]
9. Biasing human epidermal growth factor receptor 4 (her4) tyrosine kinase signaling with antibodies: Induction of cell death by antibody-dependent her4 intracellular domain trafficking.
Lanotte R; Garambois V; Gaborit N; Larbouret C; Musnier A; Martineau P; Pèlegrin A; Chardès T
Cancer Sci; 2020 Jul; 111(7):2508-2525. PubMed ID: 32415868
[TBL] [Abstract] [Full Text] [Related]
10. Poziotinib suppresses ovarian cancer stem cell growth via inhibition of her4-mediated STAT5 pathway.
Lee H; Kim JW; Choi DK; Yu JH; Kim JH; Lee DS; Min SH
Biochem Biophys Res Commun; 2020 May; 526(1):158-164. PubMed ID: 32201081
[TBL] [Abstract] [Full Text] [Related]
11. Demcizumab combined with paclitaxel for platinum-resistant ovarian, primary peritoneal, and fallopian tube cancer: The SIERRA open-label phase Ib trial.
Coleman RL; Handley KF; Burger R; Molin GZD; Stagg R; Sood AK; Moore KN
Gynecol Oncol; 2020 May; 157(2):386-391. PubMed ID: 32037195
[TBL] [Abstract] [Full Text] [Related]
12. Discrepancy in calculated and measured glomerular filtration rates in patients treated with PARP inhibitors.
Zibetti Dal Molin G; Westin SN; Msaouel P; Gomes LM; Dickens A; Coleman RL
Int J Gynecol Cancer; 2020 Jan; 30(1):89-93. PubMed ID: 31792084
[TBL] [Abstract] [Full Text] [Related]
13. Genome-wide Analysis of Common Copy Number Variation and Epithelial ovarian cancer Risk.
Reid BM; Permuth JB; Chen YA; Fridley BL; Iversen ES; Chen Z; Jim H; Vierkant RA; Cunningham JM; Barnholtz-Sloan JS; Narod S; Risch H; Schildkraut JM; Goode EL; Monteiro AN; Sellers TA
Cancer Epidemiol Biomarkers Prev; 2019 Jul; 28(7):1117-1126. PubMed ID: 30948450
[TBL] [Abstract] [Full Text] [Related]
14. Integrated Genomic, Epigenomic, and Expression Analyses of ovarian cancer Cell Lines.
Papp E; Hallberg D; Konecny GE; Bruhm DC; Adleff V; Noë M; Kagiampakis I; Palsgrove D; Conklin D; Kinose Y; White JR; Press MF; Drapkin R; Easwaran H; Baylin SB; Slamon D; Velculescu VE; Scharpf RB
Cell Rep; 2018 Nov; 25(9):2617-2633. PubMed ID: 30485824
[TBL] [Abstract] [Full Text] [Related]
15. Methylation-associated silencing of
Chen K; Liu MX; Mak CS; Yung MM; Leung TH; Xu D; Ngu SF; Chan KK; Yang H; Ngan HY; Chan DW
Theranostics; 2018; 8(2):423-436. PubMed ID: 29290818
[TBL] [Abstract] [Full Text] [Related]
16. A genetic variant of miR-335 binding site in the erbb4 3'-UTR is associated with prognosis of ovary cancer.
Wei P; Li L; Zhang Z; Zhang W; Liu M; Sheng X
J Cell Biochem; 2018 Jul; 119(7):5135-5142. PubMed ID: 29125883
[TBL] [Abstract] [Full Text] [Related]
17. ErbB Receptors and cancer.
Wang Z
Methods Mol Biol; 2017; 1652():3-35. PubMed ID: 28791631
[TBL] [Abstract] [Full Text] [Related]
18. erbb4 Expression in ovarian Serous Carcinoma Resistant to Platinum-Based Therapy.
Saglam O; Xiong Y; Marchion DC; Strosberg C; Wenham RM; Johnson JJ; Saeed-Vafa D; Cubitt C; Hakam A; Magliocco AM
Cancer Control; 2017 Jan; 24(1):89-95. PubMed ID: 28178720
[TBL] [Abstract] [Full Text] [Related]
19. Endometriosis-related infertility: ovarian endometrioma per se is not associated with presentation for infertility.
Santulli P; Lamau MC; Marcellin L; Gayet V; Marzouk P; Borghese B; Lafay Pillet MC; Chapron C
Hum Reprod; 2016 Aug; 31(8):1765-75. PubMed ID: 27130614
[TBL] [Abstract] [Full Text] [Related]
20. Dynamic modulation of phosphoprotein expression in ovarian cancer xenograft models.
Koussounadis A; Langdon SP; Um I; Kay C; Francis KE; Harrison DJ; Smith VA
BMC Cancer; 2016 Mar; 16():205. PubMed ID: 26964739
[TBL] [Abstract] [Full Text] [Related]
[Next]
